Clean Air Metals net loss widens 43% to $842,678 for six months ended July 31, 2026
Bitget2026/09/29 22:45- Clean Air Metals posted a net loss and comprehensive loss of $842,678 for the six months ended July 31, 2026, widening from $589,533.
- Operating expenses rose 13% to $852,887 for the six-month period.
- Total assets slipped to $35,465,204 as of July 31, 2026, while total liabilities edged up to $3,661,340.
- Cash fell to $422,500, and working capital remained in deficit at $3,188,114.
- Exploration spending totaled $164,309 at Thunder Bay North, and the company received a $57,000 Critical Minerals Innovation Fund grant.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
